{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:05:57Z","timestamp":1782698757817,"version":"3.54.5"},"reference-count":141,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ogc.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T09:29:10Z","timestamp":1238664550000},"page":"129-152","source":"Crossref","is-referenced-by-count":39,"title":["Polycystic Ovary Syndrome in the Adolescent"],"prefix":"10.1016","volume":"36","author":[{"given":"Samantha M.","family":"Pfeifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Kives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ogc.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jc.79.1.119","article-title":"Accelerated 24 h luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian disease","volume":"79","author":"Apter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ogc.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.80.10.2966","article-title":"Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism","volume":"80","author":"Apter","year":"1995","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.86.1.72","article-title":"Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome","volume":"86","author":"Veldhuis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/en.137.4.1265","article-title":"Testosterone is required for gonadotropin-releasing hormone stimulation of luteinizing hormone-P messenger ribonucleic acid expression in female rats","volume":"137","author":"Yasin","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ogc.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0015-0282(00)01526-0","article-title":"The time has come to simplify the evaluation of the hirsute patient","volume":"74","author":"Azziz","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism","volume":"62","author":"Barbieri","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-72-6-1308","article-title":"Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female","volume":"72","author":"DeClue","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ogc.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ogc.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0015-0282(03)00735-0","article-title":"Androgen excess is the key element in polycystic ovary syndrome","volume":"80","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0015-0282(03)00732-5","article-title":"Hyperandrogenemia is necessary but not sufficient for polycystic ovary syndrome","volume":"80","author":"Dunaif","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","article-title":"Current concepts in the polycystic ovary syndrome","volume":"52","author":"Dunaif","year":"2001","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ogc.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ogc.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention of metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jc.87.3.1017","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.suc.2005.12.015","article-title":"Adolescent obesity and bariatric surgery","volume":"86","author":"Helmrath","year":"2006","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ogc.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib26","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ogc.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ogc.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006254-200405000-00025","article-title":"Endometrial hyperplasia: a review","volume":"59","author":"Montgomery","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ogc.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0029-7844(01)01432-6","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib32","article-title":"Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome","author":"Jungheim","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajog.2003.09.058","article-title":"Obesity, obstetric complications and cesarean delivery rate\u2014a population-based screening study","volume":"190","author":"Weiss","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000107291.46159.00","article-title":"Maternal morbid obesity and the risk of adverse pregnancy outcome","volume":"103","author":"Cedergren","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib36","first-page":"196","article-title":"Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation","volume":"62","author":"Hammond","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1210\/jc.84.5.1617","article-title":"Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"84","author":"Imani","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2007-1009","article-title":"Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","article-title":"Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers","volume":"66","author":"Ching","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2008.12.004_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1367\/A04-130R.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life","volume":"5","author":"Trent","year":"2005","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.ogc.2008.12.004_bib44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/jc.79.6.1778","article-title":"Source localization of androgen excess in adolescent girls","volume":"79","author":"Ibanez","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ijo.2008.61","article-title":"Polycystic ovary syndrome in adolescents","volume":"32","author":"Franks","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ogc.2008.12.004_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpag.2007.05.001","article-title":"Adrenarche and polycystic ovary syndrome: a tale of two hypotheses","volume":"20","author":"Nader","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2005.05.006","article-title":"Insulin resistance in adolescents with menstrual irregularities","volume":"18","author":"Fernandes","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib50","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib51","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2008.12.004_bib53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2008.12.004_bib54","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.fertnstert.2006.04.015","article-title":"Clinical expression of polycystic ovary syndrome in adolescent girls","volume":"86","author":"Sultan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1196\/annals.1365.014","article-title":"Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age","volume":"1092","author":"Pasquali","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ogc.2008.12.004_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/GRF.0b013e31802f50fc","article-title":"Polycystic ovary syndrome: early detection in the adolescent","volume":"50","author":"Chang","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/713602836","article-title":"Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence","volume":"15","author":"Avvad","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ogc.2008.12.004_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1980.tb02125.x","article-title":"Serum steroids and pituitary hormones in female puberty: a partly longitudinal study","volume":"12","author":"Apter","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2008.12.004_bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1990.tb00887.x","article-title":"Hormonal studies on women with polycystic ovaries diagnosed by ultrasound","volume":"32","author":"Obhrai","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ogc.2008.12.004_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1749-6632.1997.tb52143.x","article-title":"Adolescent polycystic ovary syndrome","volume":"816","author":"Dramusic","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ogc.2008.12.004_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1083-3188(97)70072-X","article-title":"Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents","volume":"10","author":"Dramusic","year":"1997","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpedi.162.6.521","article-title":"Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?","volume":"162","author":"Rachmiel","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib64","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jc.83.10.3558","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ibanez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","article-title":"Longitudinal study of physiologic insulin resistance and metabolic changes of puberty","volume":"60","author":"Hannon","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ogc.2008.12.004_bib66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3476(89)80438-X","article-title":"Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity","volume":"114","author":"Caprio","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.ogc.2008.12.004_bib67","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/jc.2007-1036","article-title":"Early metabolic derangements in daughters of women with polycystic ovary syndrome","volume":"92","author":"Sir-Petermann","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jadohealth.2008.05.004","article-title":"Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls","volume":"43","author":"Biro","year":"2008","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.ogc.2008.12.004_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1067\/mpd.2001.109790","article-title":"The prevalence of upper lip hair in black and white girls during puberty: a new standard","volume":"138","author":"Lucky","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.ogc.2008.12.004_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0015-0282(01)01701-0","article-title":"Hyperandrogenemia in patients presenting with acne","volume":"75","author":"Slayden","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ogc.2008.12.004_bib72","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jc.84.3.975","article-title":"Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17beta-estradiol and dehydroepiandrosterone sulfate","volume":"84","author":"Ankarberg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-110-5-386","article-title":"The polycystic ovary syndrome: pathogenesis and treatment","volume":"110","author":"Barnes","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5 Alpha-reductase activity in polycystic ovary syndrome","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.12.004_bib76","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jc.74.4.836","article-title":"Longitudinal evaluation of the different gonadotropin pulsatile patterns in anovulatory cycles of young girls","volume":"74","author":"Venturoli","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib77","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(83)80678-7","article-title":"Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome","volume":"102","author":"Moll","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.ogc.2008.12.004_bib79","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/jc.75.2.508","article-title":"Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance","volume":"75","author":"Zimmermann","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib80","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1210\/jc.2006-0835","article-title":"Functional significance of polycystic-size ovaries in healthy adolescents","volume":"91","author":"Mortensen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib81","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib82","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-49-6-892","article-title":"Adrenal function in normal women and women with the polycystic ovary syndrome","volume":"49","author":"Lachelin","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib83","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.fertnstert.2005.04.039","article-title":"Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study","volume":"84","author":"Yoo","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2007.02.024","article-title":"Three-dimensional transrectal ultrasonography in adolescent patients with polycystic ovarian syndrome","volume":"98","author":"Sun","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2008.12.004_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib86","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/jcem-73-6-1327","article-title":"Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation","volume":"73","author":"Azziz","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib87","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.81.3.1237","article-title":"Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism","volume":"81","author":"Ibanez","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib88","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1210\/jc.83.8.2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.ogc.2008.12.004_bib89","first-page":"1367","article-title":"Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome","volume":"15","author":"Legro","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib90","article-title":"Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels","author":"Fruzzetti","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ogc.2008.12.004_bib92","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib93","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.80.9.2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib94","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib95","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/jc.84.4.1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib96","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropomorphic indices, ovarian physiology and fertility rate induced by diet","volume":"18","author":"Crosignani","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2008.12.004_bib97","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jama.273.5.402","article-title":"Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine","volume":"273","author":"Pate","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2008.12.004_bib99","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0025-7125(05)70230-3","article-title":"Behavioral treatment of obesity","volume":"84","author":"Wadden","year":"2000","journal-title":"Med Clin North Am"},{"issue":"Suppl 2","key":"10.1016\/j.ogc.2008.12.004_bib100","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.ogc.2008.12.004_bib101","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa022207","article-title":"A randomized trial of a low-carbohydrate diet for obesity","volume":"348","author":"Foster","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.293.1.43","article-title":"Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction","volume":"293","author":"Dansinger","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2008.12.004_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07853899909019257","article-title":"Uses and misuses of the new pharmacotherapy of obesity","volume":"31","author":"Bray","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib104","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00464-004-8827-8","article-title":"National trends in utilization and outcomes of bariatric surgery","volume":"19","author":"Trus","year":"2005","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ogc.2008.12.004_bib105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-115-12-956","article-title":"Gastrointestinal surgery for severe obesity","volume":"115","author":"National Institutes of Health Consensus Development Panel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib106","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2008.12.004_bib107","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-142-7-200504050-00013","article-title":"Meta-analysis: surgical treatment of obesity","volume":"142","author":"Maggard","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/07315724.1988.10720232","article-title":"Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery","volume":"7","author":"Deitel","year":"1988","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.ogc.2008.12.004_bib109","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1091-255X(02)00125-7","article-title":"Bariatric surgery for severely obese adolescents","volume":"7","author":"Sugerman","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ogc.2008.12.004_bib110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpedsurg.2007.09.035","article-title":"An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data","volume":"43","author":"Nadler","year":"2008","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ogc.2008.12.004_bib111","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ajog.2003.11.004","article-title":"Pregnancy after bariatric surgery is not associated with adverse perinatal outcome","volume":"190","author":"Sheiner","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib112","first-page":"363","article-title":"Pregnancy following gastric bypass for the treatment of morbid obesity","volume":"48","author":"Printen","year":"1982","journal-title":"Am Surg"},{"key":"10.1016\/j.ogc.2008.12.004_bib113","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1381\/096089204322917819","article-title":"Outcome of pregnancies after biliopancreatic diversion","volume":"14","author":"Marceau","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.ogc.2008.12.004_bib114","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.80.11.3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9378(87)90238-9","article-title":"Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone","volume":"156","author":"Jung-Hoffmann","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib116","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"issue":"1A","key":"10.1016\/j.ogc.2008.12.004_bib117","doi-asserted-by":"crossref","first-page":"130S","DOI":"10.1016\/S0002-9343(99)80071-0","article-title":"The role of oral contraceptives in the treatment of hyperandrogenic disorders","volume":"98","author":"Burkman","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ogc.2008.12.004_bib119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.85.1.89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ogc.2008.12.004_bib120","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.85.9.3251","article-title":"Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide","volume":"85","author":"Ibanez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib121","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)56518-2","article-title":"Comparison of flutamide and spironolactone n the treatment of hirsutism: a randomized controlled trial","volume":"61","author":"Cusan","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib122","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib123","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1210\/jc.80.12.3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib124","first-page":"693","article-title":"Cyclic hormone replacement therapy using quarterly progestin","volume":"83","author":"Ettinger","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.ogc.2008.12.004_bib125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(05)78345-8","article-title":"Insulin-sensitizing agents in polycystic ovary syndrome","volume":"351","author":"Sattar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.12.004_bib127","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.85.1.139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jc.87.2.569","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib129","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ogc.2008.12.004_bib130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ogc.2008.12.004_bib131","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ogc.2008.12.004_bib132","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jc.85.8.2767","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib133","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)","volume":"29","author":"Glueck","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.ogc.2008.12.004_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2008.12.004_bib135","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1210\/jc.85.10.3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ibanez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib136","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.86.8.3595","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism","volume":"86","author":"Ibanez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib137","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib138","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ogc.2008.12.004_bib139","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.12.004_bib140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2007-992930","article-title":"Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects","volume":"26","author":"Seow","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ogc.2008.12.004_bib141","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0015-0282(16)53214-2","article-title":"Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome","volume":"53","author":"Armar","year":"1990","journal-title":"Fertil Steril"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854508001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854508001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T09:08:15Z","timestamp":1710234495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854508001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0889854508001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2008.12.004","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}